No Increased DVT Risk From Testosterone Replacement.

“Despite the 2014 FDA warning of an increased risk for deep vein thrombosis (DVT) with testosterone replacement therapies,” a chart review of 1180 patients published in Urology found that “the rate of deep vein thrombosis in treated hypogonadal men was just 0.8% over 2 years of follow-up.” https://www.renalandurologynews.com/hypogonadism/study-testosterone-replacement-does-not-increase-dvt-risk/article/818600/